Gene: FANCD2
Official Full Name: FA complementation group D2provided by HGNC
Gene Summary: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00022 | FANCD2 Knockout cell line (U-2 OS) | Human | FANCD2 | 1:3~1:5 | Negative | Online Inquiry |
KO06480 | FANCD2 Knockout cell line (HeLa) | Human | FANCD2 | 1:3~1:6 | Negative | Online Inquiry |
KO06481 | FANCD2 Knockout cell line (HCT 116) | Human | FANCD2 | 1:2~1:4 | Negative | Online Inquiry |
KO06482 | FANCD2 Knockout cell line (HEK293) | Human | FANCD2 | 1:3~1:6 | Negative | Online Inquiry |
KO06483 | FANCD2 Knockout cell line (A549) | Human | FANCD2 | 1:3~1:4 | Negative | Online Inquiry |
FANCD2 Gene Knockout Cell Lines are specifically engineered human cell lines designed to study the role of the FANCD2 gene in cellular processes. FANCD2, part of the Fanconi anemia (FA) pathway, plays a critical role in DNA repair mechanisms, particularly in the recognition and repair of DNA interstrand cross-links. By knocking out the FANCD2 gene, these cell lines provide a powerful tool for elucidating the biological consequences of FANCD2 deficiency, enabling researchers to investigate its effects on DNA repair efficiency, cell cycle regulation, and cellular response to genotoxic stress.
The primary function of FANCD2 knockout cell lines lies in their ability to mimic the pathological conditions observed in Fanconi anemia, a genetic disorder characterized by increased susceptibility to cancer due to impaired DNA repair. This makes them invaluable for understanding the mechanisms of tumorigenesis and exploring potential therapeutic interventions. By providing insights into the FA pathway, these cell lines further demonstrate their importance in drug discovery, where researchers can evaluate the efficacy of novel agents targeting DNA repair mechanisms.
What sets FANCD2 Gene Knockout Cell Lines apart from alternatives is their precise genetic alteration and robust characterization. Unlike traditional cell models, these lines offer a reliable representation of FANCD2-deficient phenotypes, supported by comprehensive validation through genotyping and functional assays. Additionally, they come pre-validated with assays for cell viability, proliferation, and DNA damage response, saving researchers time and resources.
For researchers and clinicians focusing on cancer biology, cellular stress responses, or inherited genetic disorders, FANCD2 Gene Knockout Cell Lines deliver unmatched value. They serve as a critical asset for elucidating disease mechanisms, developing targeted therapies, and improving patient outcomes in Fanconi anemia and related malignancies.
Our company specializes in providing high-quality biological products tailored for advanced research needs. With a commitment to scientific excellence and innovation, we empower the scientific community to unlock new knowledge and breakthroughs in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.